Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
EW stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Edwards Lifesciences Corporation stock logo

Edwards Lifesciences Corporation

EW·NYSE

Last updated as of 2026-02-12 18:46 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

EW stock price change

On the last trading day, EW stock closed at 77.38 USD, with a price change of -2.46% for the day.
Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

EW key data

Previous close77.38 USD
Market cap44.90B USD
Volume871.95K
P/E ratio41.77
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)1.85 USD
Net income (FY)874.60M USD
Revenue (FY)5.44B USD
Next report dateApr 29, 2026
EPS estimate0.690 USD
Revenue estimate1.57B USD USD
Shares float572.37M
Beta (1Y)0.59
Tokenized stocks

Have you heard of tokenized stocks?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Edwards Lifesciences Corporation overview

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Sector
Health technology
Industry
Medical Specialties
CEO
Bernard J. Zovighian
Headquarters
Irvine
Website
edwards.com
Founded
1958
Employees (FY)
15.8K
Change (1Y)
−4K −20.20%
Revenue / Employee (1Y)
344.27K USD
Net income / Employee (1Y)
88.66K USD

EW Pulse

Daily updates on EW stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• EW Stock Price 24h change: +2.96%. From 77.05 USD to 79.33 USD.
• Following a mixed Q4 report, EW shares rebounded as investors focused on upbeat 2026 guidance despite an earnings miss ($0.58 vs $0.62 expected). Strength in Transcatheter Mitral and Tricuspid Therapies (TMTT) sales, which grew over 40%, and a confident 8-10% revenue growth forecast for 2026, drove positive sentiment.
• From a technical perspective, EW is showing a "bullish recovery within a broad consolidation range." The stock recently reclaimed its 200-day moving average (~$79.27), signaling a potential trend shift. While near-term RSI (around 44-50) remains neutral, the price action suggests a recovery toward resistance at $82-$84, supported by strong volume during recent gains.
• Wells Fargo raised its price target for EW to $100 from $96 on February 11, citing "increased confidence" in 2026 sales targets and momentum in structural heart therapies.
• On February 10, Edwards Lifesciences reported Q4 revenue of $1.57 billion, beating estimates by 13.3% YoY, while TAVR sales reached $1.16 billion, reflecting steady core business demand.
• Simply Wall St noted on February 11 that despite the top-line beat, EW faces margin pressure, with 2025 net income impacted by heavy investments in its structural heart portfolio and shifting cost structures.
• The medical device industry (AdvaMed, Medtronic, Boston Scientific) entered negotiations with the FDA on February 12 to reform the "de novo" and pre-submission programs to improve approval efficiency for novel technologies.
• The FDA finalized two major guidance documents on February 10 regarding cybersecurity and computer software assurance for medical devices, requiring manufacturers to implement risk-based frameworks for AI and cloud computing integrations.
See more
about 7h ago
• EW Stock Price 24h change: +1.75%. From 77.05 USD to 78.40 USD. (As of February 11, 2026).
• From a technical perspective, EW is currently in a "bearish consolidation" phase: the stock recently hit oversold territory with an RSI around 29-34, and while it saw a minor rebound today, it remains below its 50-day ($83.98) and 200-day ($81.16) moving averages, suggesting significant overhead resistance and a prevailing downward trend.
• Edwards Lifesciences reported Q4 2025 earnings on Feb 10, posting a profit miss ($0.58 EPS vs. $0.61 expected) but a revenue beat ($1.57B vs. $1.54B), leading to a mixed market reaction and cautious 2026 guidance.
• The company issued 2026 full-year EPS guidance of $2.90–$3.05 and projected sales growth of 8%-10%, focusing on the expansion of its TAVR and TMTT heart valve therapies despite margin pressures.
• Analysts maintain a "Moderate Buy" consensus with an average target price of $96.77, though some firms like Barclays raised targets to $104 following the recent strategic update.
• The FDA released updated final guidance on February 10 regarding Cybersecurity in Medical Devices and Quality Management System considerations, impacting pre-market submission requirements for the sector.
• MedTech industry discussions this week shifted toward the impact of a full year of potential tariffs and the restart of Medical Device User Fee Amendments (MDUFA VI) negotiations between industry groups and the FDA.
See more
about 1D ago

EW stock price forecast

According to technical indicators for EW stock, the price is likely to fluctuate within the range of 78.85–88.05 USD over the next week. Market analysts predict that the price of EW stock will likely fluctuate within the range of 76.94–117.19 USD over the next months.

Based on 1-year price forecasts from 59 analysts, the highest estimate is 132.71 USD, while the lowest estimate is 54.40 USD.

For more information, please see the EW stock price forecast Stock Price Forecast page.

Latest EW stock news

Bitcoin News Update: Report Reveals Bitcoin’s Future Depends on Macroeconomic Transparency and Trust from Institutions

Bitget-RWA2025-11-26 12:34:13

Bitcoin News Update: Major Institutions Wager on Bitcoin’s Long-Term Potential as Expectations of Fed Rate Cuts Drive Surge to $93K

Bitget-RWA2025-11-28 17:50:31

Bitcoin News Update: December Outlook for Bitcoin Hinges on Fed's Rate Cut Indications and End of Quantitative Tightening

Bitget-RWA2025-12-01 03:24:14

Infrastructure-Fueled Growth in Industrial Property Across Upstate New York

Bitget-RWA2025-12-02 01:50:06

Titan OS secures $58 million in funding from Highland Europe to advance its smart TV operating system

Bitget-RWA2025-12-02 17:09:29

Wall Street believes the likelihood of a recession is minimal, but a pessimistic analyst argues that this chart suggests the opposite.

101 finance2026-01-08 18:33:24

FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve

101 finance2026-01-09 21:27:10

Popular Burger restaurant Steak ’n Shake acquires $10 million worth of bitcoin

101 finance2026-01-17 17:36:31

Britain ‘faces potential recession’ due to £22bn Trump tariff impact

101 finance2026-01-19 19:51:38

5 Essential Analyst Inquiries From United Community Banks’s Q4 Earnings Conference Call

101 finance2026-01-21 10:09:29

Zanskar believes that 1 terawatt of geothermal energy is not receiving enough attention

101 finance2026-01-21 13:06:16

Geothermal Wildcatter Zanskar, Leveraging AI to Locate Geothermal Resources, Secures $115 Million in Funding

101 finance2026-01-21 13:12:32

Dow 50,000 milestone puts focus on inflation figures and postponed January employment data: Key events to monitor this week

101 finance2026-02-08 12:42:39

Edwards Lifesciences recently revealed that its management has significantly increased confidence in achieving its 2026 financial targets.

老虎证券2026-02-10 21:21:00

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

Finviz2026-02-12 18:27:41

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Edwards Lifesciences Corporation?

EW is currently priced at 77.38 USD — its price has changed by -2.46% over the past 24 hours. You can track the stock price performance of Edwards Lifesciences Corporation more closely on the price chart at the top of this page.

What is the stock ticker of Edwards Lifesciences Corporation?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Edwards Lifesciences Corporation is traded under the ticker EW.

What is the stock forecast of EW?

We've gathered analysts' opinions on Edwards Lifesciences Corporation's future price. According to their forecasts, EW has a maximum estimate of 773.80 USD and a minimum estimate of 154.76 USD.

What is the market cap of Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation has a market capitalization of 44.90B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
EW